id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
EPA-HQ-OPP-2022-0772-0017,EPA,EPA-HQ-OPP-2022-0772,Memorandum Supporting Final Decision to Approve Registration for the New Active Ingredient Veratrine,Supporting & Related Material,Decision,2025-01-13T05:00:00Z,2025,1,,,2025-01-14T01:34:59Z,,0,0,09000064868a71cc
EPA-HQ-OPP-2022-0772-0018,EPA,EPA-HQ-OPP-2022-0772,Veratrine: Response to Public comments on EPA’s Proposed Registration of the New Active Ingredient Veratrine,Supporting & Related Material,Comment Response,2025-01-13T05:00:00Z,2025,1,,,2025-01-14T01:34:46Z,,0,0,09000064868a72d2
EPA-HQ-OPP-2022-0772-0012,EPA,EPA-HQ-OPP-2022-0772,1021-EITR Label 22 Oct. 22. 2024 MGK Formula 31731,Supporting & Related Material,,2024-11-13T05:00:00Z,2024,11,,,2024-11-14T01:55:10Z,,0,0,0900006486803c83
EPA-HQ-OPP-2022-0772-0013,EPA,EPA-HQ-OPP-2022-0772,1021-EITN Label Oct. 22. 2024 MGK Formula 3159,Supporting & Related Material,,2024-11-13T05:00:00Z,2024,11,,,2024-11-14T01:54:43Z,,0,0,0900006486803c84
EPA-HQ-OPP-2022-0772-0014,EPA,EPA-HQ-OPP-2022-0772,1021-EIAI Label Oct. 22. 2024 MGK Formula 31421,Supporting & Related Material,,2024-11-13T05:00:00Z,2024,11,,,2024-11-14T01:54:57Z,,0,0,0900006486803c85
EPA-HQ-OPP-2022-0772-0011,EPA,EPA-HQ-OPP-2022-0772,1021-EIAO Label Oct. 22. 2024 MGK Formula 31422 Aerosol,Supporting & Related Material,,2024-11-08T05:00:00Z,2024,11,,,2024-11-09T01:35:50Z,,0,0,0900006486803c82
EPA-HQ-OPP-2022-0772-0004,EPA,EPA-HQ-OPP-2022-0772,"SABA-10: Summary of Hazard and Science Policy Council (HASPOC) Meeting on October 29, 2020: Recommendations on the Need for a Subchronic Dog Study, an Immunotoxicity Study, and a Subchronic Inhalation Study",Supporting & Related Material,Meeting Materials,2024-10-31T04:00:00Z,2024,10,,,2024-11-01T00:36:09Z,,0,0,09000064867de01b
EPA-HQ-OPP-2022-0772-0007,EPA,EPA-HQ-OPP-2022-0772,Veratrine: Human Health Risk Assessment to Support the Registration of a New Active Ingredient Assessment for a Proposed Outdoor Use on the Exterior Vertical Surface of Structures,Supporting & Related Material,Risk Assessment,2024-10-31T04:00:00Z,2024,10,,,2024-11-01T00:36:44Z,,0,0,09000064867de01e
EPA-HQ-OPP-2022-0772-0005,EPA,EPA-HQ-OPP-2022-0772,Veratrine: Environmental Fate and Ecological Risk Assessment and Biological Evaluation (BE) for Proposed Section 3 New Chemical Registration,Supporting & Related Material,Risk Assessment,2024-10-31T04:00:00Z,2024,10,,,2024-11-01T00:36:21Z,,0,0,09000064867de01c
EPA-HQ-OPP-2022-0772-0002,EPA,EPA-HQ-OPP-2022-0772,Public Participation for New Active Ingredient Veratrine,Other,Public Participation,2024-10-31T04:00:00Z,2024,10,2024-10-31T04:00:00Z,2024-11-29T04:59:59Z,2024-11-27T02:01:00Z,,0,0,09000064867eafa6
EPA-HQ-OPP-2022-0772-0003,EPA,EPA-HQ-OPP-2022-0772,Veratrine: Addendum to the Human Health Risk Assessment to Support the Registration of the New Active Ingredient and the Proposed Outdoor Use on Exterior Vertical Surface of Structures,Supporting & Related Material,Risk Assessment,2024-10-31T04:00:00Z,2024,10,,,2024-11-01T00:35:57Z,,0,0,09000064867de01a
EPA-HQ-OPP-2022-0772-0006,EPA,EPA-HQ-OPP-2022-0772,"SABA-10: Summary of Hazard and Science Policy Council (HASPOC) Meeting on April 13, 2023: Recommendation on the Need for an Immunotoxicity Study",Supporting & Related Material,Meeting Materials,2024-10-31T04:00:00Z,2024,10,,,2024-11-01T00:36:33Z,,0,0,09000064867de01d
EPA-HQ-OPP-2022-0772-0008,EPA,EPA-HQ-OPP-2022-0772,Memorandum Supporting Proposed Decision to Approve Registration for the New Active Ingredient Veratrine,Supporting & Related Material,Decision,2024-10-31T04:00:00Z,2024,10,,,2024-11-01T00:37:08Z,,0,0,09000064867eae47
EPA-HQ-OPP-2022-0772-0001,EPA,EPA-HQ-OPP-2022-0772,"Pesticide Product Registration: Applications for New Active Ingredients, January 2023",Notice,,2023-02-23T05:00:00Z,2023,2,2023-02-23T05:00:00Z,2023-03-28T03:59:59Z,2023-03-05T20:28:06Z,2023-03748,0,0,09000064856f52ce